spacer
home > ict > autumn 2018 > does size matter?
PUBLICATIONS
International Clinical Trials

Does Size Matter?

CROs of different sizes are recognising the increasing need for small sponsor companies to get support in conducting clinical trials. Generally, these CROs, even the smaller ones, have a larger organisation than the small sponsor companies.

Most of the small sponsors depend on external funding, like venture capital, private equity, public funding, or funding through large pharmaceutical companies. They depend on being extremely cost-effective in conducting their clinical trial, with limited resources to perform their vendor oversight and management. One single clinical trial can be a ‘make or break’ milestone for the small sponsor companies. Single achieved milestones, like the positive approval of the clinical trial submission, the timely ‘First Subject In’, creates shareholder value, positive press releases, and awareness for potential investors. The outcome of the clinical trial, the achieved company milestone, can be an indicator for the success of the next financial investment round.

The business model for small early clinical stage sponsor companies is not to make revenues, but to develop innovative compounds which can be sold or partnered profitably at different stages of the drug development cycle before market authorisation. Small sponsor companies are known for their innovation, flat hierarchies, and, sometimes, unconventional decision-making processes.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Heike Schön, Managing Director at LUMIS International, has more than 25 years of experience in leadership positions in international clinical research and drug development in CROs and biotechnology companies. She has a profound knowledge of clinical drug development processes and regulatory requirements from first-in-human trials to market access. As General Manager, Heike gained experience in leading and developing a CRO, which she implemented successfully at LUMIS International. One of her main activities is supporting small biotech companies in setting up their clinical research department and oversight management.
spacer
Heike Schön
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers

Spotlight on Quality in Study Startup

Oracle Health Sciences

This white paper addresses the growing interest in quality in clinical trial execution and how workflows play an essential role by building in the steps needed to comply with TMF guidelines, reducing downstream problems. This proactive strategy limits issues caused by siloes, yielding process improvements measurable by performance metrics.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement